4//SEC Filing
SAVIENT PHARMACEUTICALS INC 4
Accession 0001230295-08-000008
CIK 0000722104operating
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:48 PM ET
Size
11.2 KB
Accession
0001230295-08-000008
Insider Transaction Report
Form 4
HAYDEN BRIAN J
SVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2008-01-02$5.33/sh−5,000$26,650→ 125,000 totalExercise: $5.33From: 2007-07-05Exp: 2016-07-05→ Common Stock, $.01 par value per share (5,000 underlying) - Sale
Common Stock, $.01 par value per share
2008-01-03$24.26/sh−5,000$121,286→ 26,910 total - Exercise/Conversion
Common Stock, $.01 par value per share
2008-01-02$5.33/sh+5,000$26,650→ 36,910 total - Sale
Common Stock, $.01 par value per share
2008-01-02$23.47/sh−5,000$117,361→ 31,910 total
Footnotes (3)
- [F1]This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934.
- [F2]Represents the average sale price. The highest price at which shares were sold was $23.9401 and the lowest price at which shares were sold was $23.24.
- [F3]Represents the average sale price. The highest price at which shares were sold was $24.47 and the lowest price at which shares were sold was $24.07.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000722104
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:48 PM ET
- Size
- 11.2 KB